These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6972874)
1. Implantation of mouse histocompatibility antigens into membranes of cultured tumor cells. Volsky DJ; Ahrlund-Richter L; Dalianis T; Klein G Eur J Immunol; 1981 Apr; 11(4):341-4. PubMed ID: 6972874 [TBL] [Abstract][Full Text] [Related]
2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
3. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells. Hale AH; Ruebush MJ; Harris DT; McGee MP J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes. Ciavarra R; Kang CY; Forman J Fed Proc; 1981 Feb; 40(2):222-7. PubMed ID: 6257559 [TBL] [Abstract][Full Text] [Related]
5. Minimal molecular requirements for reactivity of tumor cells with T cells. Hale AH; Lyles DS; Paulus LK; Ruebush MJ J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133 [TBL] [Abstract][Full Text] [Related]
6. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
7. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response. Yu AS; Bernstein ID J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788 [TBL] [Abstract][Full Text] [Related]
8. Introduction of HLA-A/B antigens into lymphoid cell membranes by cell-liposome fusion. Correa-Freire MC; Powers GA; Engelhard VH J Immunol; 1984 Jan; 132(1):69-75. PubMed ID: 6361126 [TBL] [Abstract][Full Text] [Related]
9. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors. Bevan MJ J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256 [TBL] [Abstract][Full Text] [Related]
10. [Role of H-2 region in cytolysis of viral induced lymphomas by T lymphocytes]. Gomard E; Duprez V; Lévy JP Ann Immunol (Paris); 1977; 128(1-2):7-9. PubMed ID: 300611 [TBL] [Abstract][Full Text] [Related]
11. Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells. Callahan GN; Allison JP; Pellegrino MA; Reisfeld RA J Immunol; 1979 Jan; 122(1):70-4. PubMed ID: 762424 [TBL] [Abstract][Full Text] [Related]
12. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells. Altevogt P; Leidig S; Heckl-Oestreicher B Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273 [TBL] [Abstract][Full Text] [Related]
13. CT hybridomas: tumor cells capable of lysing virally infected target cells. Whitaker RB; Kauffman RS; Che M; Finberg R J Immunol; 1982 Aug; 129(2):900-3. PubMed ID: 6282974 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes. Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874 [TBL] [Abstract][Full Text] [Related]
15. The relationship of membrane antigens on 141 (NZB) and EL4 (C57BL) lymphoma cells as demonstrated by antibody-induced resistance to complement-mediated cytotoxicity. Ran M; Yaakubowicz M; Talal N; Witz IP Eur J Immunol; 1978 Jun; 8(6):423-8. PubMed ID: 78855 [TBL] [Abstract][Full Text] [Related]
16. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells. Devens B; Naor D J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839 [TBL] [Abstract][Full Text] [Related]
17. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes. Hale AH; Lyles DS; Fan DP J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330 [TBL] [Abstract][Full Text] [Related]
18. H-2-linked murine cytotoxic T cell responses specific for sendai virus-infected cells. Kurrle R; Röllinghoff M; Wagner H Eur J Immunol; 1978 Dec; 8(12):910-2. PubMed ID: 83237 [TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells. Pilarski LM; Carayanniotis G J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580 [TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces. Coutinho A; Augustin AA Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]